BriaCell Therapeutics's total assets for Q4 2024 were $5.87M, a decrease of -5.34% from the previous quarter. TSE:BCT total liabilities were $8.56M for the fiscal quarter, a -31.19% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.